Viridian Therapeutics Inc. (VRDN)
NASDAQ · Healthcare
Viridian Therapeutics Inc. Revenue 2013–2025
Viridian Therapeutics Inc. annual/quarterly revenue history and growth rate from 2013 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Viridian Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 141000, a 95.83% increase year-over-year.
- Viridian Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 70.9 M, a 23362.91% increase year-over-year.
- Viridian Therapeutics Inc. annual revenue for 2025 was 70.8 M, a 23359.93% increase from 2024.
- Viridian Therapeutics Inc. annual revenue for 2024 was 302000, a 3.82% decrease from 2023.
- Viridian Therapeutics Inc. annual revenue for 2023 was 314000, a 82.28% decrease from 2022.
- Viridian Therapeutics Inc. annual revenue for 2022 was 1.8 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Viridian Therapeutics Inc. Market Cap — FAQ
Viridian Therapeutics Inc. (VRDN) market cap over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRDN's market cap history?
The chart and table above show Viridian Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.